H.R. 8839 aims to improve the health and support for cancer survivors by addressing their needs throughout the entire process of cancer care, from diagnosis and treatment to recovery. The bill focuses on enhancing survivorship and ensuring that individuals who have battled cancer receive the necessary resources and assistance during their transition back to normal life after treatment.
Media coverage has highlighted H.R. 8839 as a crucial step towards recognizing and addressing the unique challenges faced by cancer survivors. Advocates have praised the bill for its comprehensive approach to survivorship, emphasizing the importance of continuous care and support that can significantly improve the quality of life for those affected by cancer.
Some critics have raised concerns about the potential costs associated with implementing the provisions of H.R. 8839. There are fears that the bill may lead to increased healthcare spending without clear measures to ensure effective outcomes for survivors. Additionally, skeptics argue that the bill may not adequately address the root issues faced by cancer survivors, leading to calls for more targeted solutions.
The analysis of H.R. 8839, which focuses on improving the health and care of cancer survivors, reveals no direct industry overlaps between the bill's subject matter and the top donor industries of sponsor Debbie Wasserman Schultz. While there is lobbying activity in the healthcare sector, the contributions from specific entities such as Paratek Pharmaceuticals ($20,000) and Church Alliance ($10,000) do not directly relate to cancer survivorship or treatment. The undisclosed amounts from other lobbying entities further complicate the picture but do not indicate a clear conflict with the bill's intent. Overall, the lack of direct financial ties to the bill's subject suggests a low risk of conflict of interest.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| STEELSHIPS, LLC | CONSCIENCE POINT CONSULTING, INC. | $45,000 |
| SAN PASQUAL BAND OF MISSION INDIANS | THE FARLEY GROUP, INC. | $30,000 |
| PARATEK PHARMACEUTICALS | PARATEK PHARMACEUTICALS | $20,000 |
| SAN JUAN SOUTHERN PAIUTE TRIBE | THE FARLEY GROUP, INC. | $15,000 |
| CHURCH ALLIANCE | K&L GATES, LLP | $10,000 |
| GIFDA | RULON & WHITE GOVERNANCE STRATEGIES | $10,000 |
| ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY | ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY | undisclosed |
| PHARMATROPHIX, INC. | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | undisclosed |
| PGA TOUR, INC. | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | undisclosed |
| RESPONSIVE GOV ACTION | THE RABEN GROUP | undisclosed |
| KERECIS | INVARIANT LLC | undisclosed |
| BINTI, INC. | INVARIANT LLC | undisclosed |
| VERTIV GROUP CORPORATION | AKIN GUMP STRAUSS HAUER & FELD | undisclosed |
| TERRA-GEN, LLC | AKIN GUMP STRAUSS HAUER & FELD | undisclosed |
| PHILIPS | CONTINENTAL STRATEGY, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Debbie Wasserman Schultz, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
